OPHTHOTECH CORP's ticker is OPHT and the CUSIP is 683745103.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2019 | $1,658,000 | +26.6% | 1,175,474 | +7.7% | 0.01% | +16.7% |
| Q4 2018 | $1,310,000 | -54.4% | 1,091,347 | -10.3% | 0.01% | -50.0% |
| Q3 2018 | $2,872,000 | -9.7% | 1,216,555 | +4.5% | 0.01% | -14.3% |
| Q2 2018 | $3,179,000 | +62.9% | 1,164,268 | +63.5% | 0.01% | +75.0% |
| Q1 2018 | $1,951,000 | +213.7% | 712,141 | +257.1% | 0.01% | +166.7% |
| Q4 2017 | $622,000 | +1627.8% | 199,408 | +1318.5% | 0.00% | – |
| Q2 2017 | $36,000 | -98.3% | 14,058 | -97.6% | 0.00% | -100.0% |
| Q1 2017 | $2,157,000 | +1639.5% | 589,335 | +24641.2% | 0.01% | +900.0% |
| Q2 2015 | $124,000 | +4.2% | 2,382 | -10.2% | 0.00% | 0.0% |
| Q4 2014 | $119,000 | – | 2,654 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| SV Health Investors, LLC | 2,053,143 | $95,533,000 | 31.57% |
| Clarus Ventures, LLC | 1,554,744 | $72,342,000 | 30.07% |
| Novo Holdings A/S | 4,910,487 | $228,485,000 | 19.43% |
| JHL Capital Group LLC | 3,265,000 | $151,920,000 | 13.98% |
| AlpInvest Partners B.V. | 37,500 | $1,745,000 | 3.26% |
| Opaleye Management Inc. | 105,000 | $4,886,000 | 2.27% |
| IMA Wealth, Inc. | 67,930 | $3,161,000 | 1.54% |
| Hillview Capital Advisors, LLC | 34,830 | $1,621,000 | 1.40% |
| Cheyne Capital Management (UK) LLP | 124,151 | $5,777,000 | 1.39% |
| WILLIAM HARRIS INVESTORS INC | 106,158 | $4,939,000 | 1.30% |